Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in heart failure patients with mid-range and preserved ejection fraction and clinical outcomes: from the KCHF Registry

25 May 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Rapid Fire 4 - Chronic heart failure - Pharmacology Pharmacotherapy HFA Premium Access Heart Failure 2019

ESC 365 is supported by

ESC 365 is supported by